We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2331:HKEXLi Ning Company Limited Analysis

Data as of 2026-06-12 - not real-time

NT$21.40

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Elitegroup trades at 21.4 TWD, sitting just below its 20‑day SMA (21.52) and marginally above the 50‑day SMA (21.21), indicating a neutral price stance. The RSI of 48.9 suggests neither overbought nor oversold conditions, while the MACD histogram remains negative, pointing to short‑term bearish momentum. Volume is on an upward trend, yet the stock exhibits very high 30‑day volatility (~64%) and a modest beta of 0.73, implying sensitivity to market swings but lower systematic risk. On the valuation front, the trailing PE of 15.3 is far below the industry average of 36.5, and the DCF‑derived fair value of 36.1 TWD more than 60% above the current price, flagging a clear undervaluation. Fundamental metrics show robust revenue growth of 40.7% YoY, but margins are thin (gross 9.6%, operating 0.4%) and ROE modest at 2.5%. The balance sheet is strong with cash of 9.9 bn TWD versus debt of 1.6 bn TWD, and a low payout ratio (15%) supports the 1.02% dividend yield as sustainable.
Overall, the stock appears priced well below intrinsic estimates, backed by solid cash generation and low leverage, but the thin profitability and high volatility in the competitive computer hardware sector temper enthusiasm. Investors should weigh the upside from valuation gaps against the risk of margin pressure and sector cyclicality.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • MACD bearish histogram
  • Volume increasing but price near short‑term SMAs
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair value far above market price
  • Revenue growth exceeding 40% YoY
  • Strong cash position and low leverage

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained undervaluation relative to peers
  • Diversified product portfolio in emerging IoT and wearables
  • Low dividend payout ratio ensuring earnings retention

Key Metrics & Analysis

Financial Health

Revenue Growth40.70%
Profit Margin1.29%
P/E Ratio15.3
ROE2.48%
ROA0.35%
Debt/Equity14.85
P/B Ratio1.1
Op. Cash FlowNT$77.2M
Free Cash FlowNT$330.9M
Industry P/E36.5

Technical Analysis

TrendNeutral
RSI48.9
SupportNT$18.60
ResistanceNT$26.50
MA 20NT$21.52
MA 50NT$21.21
MA 200NT$22.11
MACDBearish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair ValueNT$36.09
GradeUndervalued
TypeBlend
Dividend Yield1.02%

Risk Assessment

Beta0.73
Volatility64.20%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.